Journal of Neuro-Oncology

, Volume 86, Issue 1, pp 109–122

New prospects for management and treatment of inoperable and recurrent skull base meningiomas

  • Mahlon D. Johnson
  • Burak Sade
  • Michael T. Milano
  • Joung H. Lee
  • Steven A. Toms
Invited Manuscript

DOI: 10.1007/s11060-007-9434-z

Cite this article as:
Johnson, M.D., Sade, B., Milano, M.T. et al. J Neurooncol (2008) 86: 109. doi:10.1007/s11060-007-9434-z

Abstract

Skull base, including optic nerve, cavernous sinus, clival and foramen magnum tumors represent a major challenge for neurosurgeons and neuro-oncologists. Growth regulatory signaling pathways for these tumors are of increasing interest as potential targets for new chemotherapy. Those differentially activated in various grades of meningiomas are currently being identified as well. This article reviews some recent findings pathways that appear to regulate meningioma growth. Potential targets for novel therapies are also discussed.

Keywords

Meningiomas Skull base Chemotherapy MAPK Akt COX-2 inhibitors PLC-gamma 

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Mahlon D. Johnson
    • 1
  • Burak Sade
    • 2
  • Michael T. Milano
    • 3
  • Joung H. Lee
    • 2
  • Steven A. Toms
    • 2
  1. 1.Department of Pathology and Laboratory Medicine, Division of NeuropathologyUniversity of Rochester Medical CenterRochesterUSA
  2. 2.Brain Tumor and Neuro-oncology CenterNeurological Institute, Cleveland ClinicClevelandUSA
  3. 3.Department of Radiation OncologyUniversity of Rochester, Medical CenterRochesterUSA

Personalised recommendations